PURPOSE: Tissue engineering has shown promise for patients requiring bladder reconstruction secondary to diverse diseases such as spina bifida and tuberculosis. In this study we addressed whether urothelium in conjunction with an acellular bladder matrix is necessary for the recruitment of host cells to repopulate the graft and whether the urothelium facilitates trans-differentiation of host fibroblastic cells into bladder smooth muscle type cells. MATERIALS AND METHODS: Urothelium from embryonic mice and rats (E18) was microdissected from bladder stroma after enzymatic digestion with 10 mM ethylenediaminetetraacetic acid. Acellular bladder matrix was prepared from postnatal day 1 rat and mouse pups using a combination of membrane disruption and DNA digestion. Urothelium was placed inside the bladder matrix and then grown either underneath the renal capsule or subcutaneously in athymic mice for 2 to 24 weeks. Grafts were sectioned and immunocytochemistry was performed with antibodies for alpha-actin smooth muscle, uroplakin, cytokeratins and vimentin to assess for the development of detrusor muscle. RESULTS: Embryonic bladder urothelium resulted in ingrowth of fibroblasts into acellular matrix in greater than 85% of 60 grafts consisting of acellular matrix and bladder urothelium. Moreover, there was apparent trans-differentiation of these fibroblasts into a smooth muscle phenotype. This smooth muscle development occurred in a graded, incremental fashion starting as early as 3 weeks and resulting in almost complete repopulation of the matrix at 6 months. CONCLUSIONS: These data support the hypothesis that epithelial mesenchymal signaling is important for the differentiation of bladder smooth muscle. Smooth muscle development during augmentation with acellular matrix is facilitated by the placement of epithelia onto the surface of the matrix.
PURPOSE: Tissue engineering has shown promise for patients requiring bladder reconstruction secondary to diverse diseases such as spina bifida and tuberculosis. In this study we addressed whether urothelium in conjunction with an acellular bladder matrix is necessary for the recruitment of host cells to repopulate the graft and whether the urothelium facilitates trans-differentiation of host fibroblastic cells into bladder smooth muscle type cells. MATERIALS AND METHODS: Urothelium from embryonic mice and rats (E18) was microdissected from bladder stroma after enzymatic digestion with 10 mM ethylenediaminetetraacetic acid. Acellular bladder matrix was prepared from postnatal day 1 rat and mouse pups using a combination of membrane disruption and DNA digestion. Urothelium was placed inside the bladder matrix and then grown either underneath the renal capsule or subcutaneously in athymic mice for 2 to 24 weeks. Grafts were sectioned and immunocytochemistry was performed with antibodies for alpha-actin smooth muscle, uroplakin, cytokeratins and vimentin to assess for the development of detrusor muscle. RESULTS:Embryonic bladder urothelium resulted in ingrowth of fibroblasts into acellular matrix in greater than 85% of 60 grafts consisting of acellular matrix and bladder urothelium. Moreover, there was apparent trans-differentiation of these fibroblasts into a smooth muscle phenotype. This smooth muscle development occurred in a graded, incremental fashion starting as early as 3 weeks and resulting in almost complete repopulation of the matrix at 6 months. CONCLUSIONS: These data support the hypothesis that epithelial mesenchymal signaling is important for the differentiation of bladder smooth muscle. Smooth muscle development during augmentation with acellular matrix is facilitated by the placement of epithelia onto the surface of the matrix.
Authors: Eric W Deutsch; Catherine A Ball; Jules J Berman; G Steven Bova; Alvis Brazma; Roger E Bumgarner; David Campbell; Helen C Causton; Jeffrey H Christiansen; Fabrice Daian; Delphine Dauga; Duncan R Davidson; Gregory Gimenez; Young Ah Goo; Sean Grimmond; Thorsten Henrich; Bernhard G Herrmann; Michael H Johnson; Martin Korb; Jason C Mills; Asa J Oudes; Helen E Parkinson; Laura E Pascal; Nicolas Pollet; John Quackenbush; Mirana Ramialison; Martin Ringwald; David Salgado; Susanna-Assunta Sansone; Gavin Sherlock; Christian J Stoeckert; Jason Swedlow; Ronald C Taylor; Laura Walashek; Anthony Warford; David G Wilkinson; Yi Zhou; Leonard I Zon; Alvin Y Liu; Lawrence D True Journal: Nat Biotechnol Date: 2008-03 Impact factor: 54.908
Authors: Pablo Gomez; Eun Seok Gil; Michael L Lovett; Danielle N Rockwood; Dolores Di Vizio; David L Kaplan; Rosalyn M Adam; Carlos R Estrada; Joshua R Mauney Journal: Biomaterials Date: 2011-07-20 Impact factor: 12.479
Authors: Joshua R Mauney; Glenn M Cannon; Michael L Lovett; Edward M Gong; Dolores Di Vizio; Pablo Gomez; David L Kaplan; Rosalyn M Adam; Carlos R Estrada Journal: Biomaterials Date: 2010-10-15 Impact factor: 12.479
Authors: Xiang-Tian Kong; Fang-Ming Deng; Ping Hu; Feng-Xia Liang; Ge Zhou; Anna B Auerbach; Nancy Genieser; Peter K Nelson; Edith S Robbins; Ellen Shapiro; Bechara Kachar; Tung-Tien Sun Journal: J Cell Biol Date: 2004-12-20 Impact factor: 10.539
Authors: Charles C Peyton; David Burmeister; Bryon Petersen; Karl-Erik Andersson; George Christ Journal: PLoS One Date: 2012-10-12 Impact factor: 3.240
Authors: Jan Adamowicz; Marta Pokrywczyńska; Jakub Tworkiewicz; Tomasz Kowalczyk; Shane V van Breda; Dominik Tyloch; Tomasz Kloskowski; Magda Bodnar; Joanna Skopinska-Wisniewska; Andrzej Marszałek; Malgorzata Frontczak-Baniewicz; Tomasz A Kowalewski; Tomasz Drewa Journal: PLoS One Date: 2016-01-14 Impact factor: 3.240